chr14-62981039-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_139318.5(KCNH5):c.775C>T(p.Leu259=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000435 in 1,614,140 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0024 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 2 hom. )
Consequence
KCNH5
NM_139318.5 synonymous
NM_139318.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.07
Genes affected
KCNH5 (HGNC:6254): (potassium voltage-gated channel subfamily H member 5) This gene encodes a member of voltage-gated potassium channels. Members of this family have diverse functions, including regulating neurotransmitter and hormone release, cardiac function, and cell volume. This protein is an outward-rectifying, noninactivating channel. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 14-62981039-G-A is Benign according to our data. Variant chr14-62981039-G-A is described in ClinVar as [Benign]. Clinvar id is 461400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.07 with no splicing effect.
BS2
High AC in GnomAd4 at 360 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNH5 | NM_139318.5 | c.775C>T | p.Leu259= | synonymous_variant | 6/11 | ENST00000322893.12 | |
KCNH5 | NM_172375.3 | c.775C>T | p.Leu259= | synonymous_variant | 6/10 | ||
KCNH5 | XM_047431275.1 | c.775C>T | p.Leu259= | synonymous_variant | 6/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNH5 | ENST00000322893.12 | c.775C>T | p.Leu259= | synonymous_variant | 6/11 | 1 | NM_139318.5 | P1 | |
KCNH5 | ENST00000420622.6 | c.775C>T | p.Leu259= | synonymous_variant | 6/10 | 1 | |||
KCNH5 | ENST00000394964.3 | n.940C>T | non_coding_transcript_exon_variant | 6/7 | 1 | ||||
KCNH5 | ENST00000394968.2 | c.601C>T | p.Leu201= | synonymous_variant | 6/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00236 AC: 359AN: 152158Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
359
AN:
152158
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000525 AC: 132AN: 251306Hom.: 1 AF XY: 0.000361 AC XY: 49AN XY: 135820
GnomAD3 exomes
AF:
AC:
132
AN:
251306
Hom.:
AF XY:
AC XY:
49
AN XY:
135820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000234 AC: 342AN: 1461864Hom.: 2 Cov.: 32 AF XY: 0.000199 AC XY: 145AN XY: 727232
GnomAD4 exome
AF:
AC:
342
AN:
1461864
Hom.:
Cov.:
32
AF XY:
AC XY:
145
AN XY:
727232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00236 AC: 360AN: 152276Hom.: 1 Cov.: 33 AF XY: 0.00224 AC XY: 167AN XY: 74446
GnomAD4 genome
AF:
AC:
360
AN:
152276
Hom.:
Cov.:
33
AF XY:
AC XY:
167
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at